Adaptive Biotechnologies’ $345 Million Initial Public Offering

Ambrogio Visconti

DLA Piper advised Adaptive Biotechnologies Corporation on its IPO, and Fenwick & West advised the underwriters. The Seattle-based Adaptive Biotechnologies Corporation (ADPT) is a commercial-stage biotechnology…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now